Company Summary
Search
Home Page
 
LSL Pharma Group Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
July 31TradingN
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
12/Jul/2010  Canada   
Exchange Filing Office
Location
Montreal Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Pharmaceutical And Medicine Manufacturing  N/cons on a "25" old for "1" new basis, "ILE.H" TO "LSL" from NEX to TSX Venture eff 1Mar2023  
Securities
SymbolSecurity NameMarketStatus
LSLLSL Pharma Group Inc.TSX VentureTRADING
Name HistoryFromTo
LSL Pharma Group Inc.1/Mar/2023Present
Company Facts Reconciliation
SubjectDate Returned
Spring 2015 CFR Not Received
Associations
Auditing Firm:  Raymond Chabot Grant Thornton, LLP
Sponsor:  Macquarie Private Wealth Inc.
Transfer Agent:  CST Trust Company
Latest Information
TypeDateTitle
News Releases  3/Aug/2017  NEWS RELEASE - CORPORATION EXPLORATION ILEDOR: ACQUISTION OF DISTURBANCE-CHANGE OF NAME-CONSOLIDATION-CONCURRENT PRIVATE PLACEMENTS[MARKETWIRE]
    NEWS RELEASE - ASC CEASE TRADE ORDER RE ILEDOR EXPLORATION CORP[MARKET NEWS]
    NEWS RELEASE - TRANSFER AND NEW ADDITION TO NEX SYMBOL CHANGE[MARKET NEWS]
Bulletins  5/Mar/2026  Convertible Debentures
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data